Efficacy of Ritlecitinib in Patients With Alopecia Areata by Extent of Hair Loss at Baseline: Post Hoc Analysis of the Phase 3 Long-Term ALLEGRO-LT Study
August 2024
in “
British Journal of Dermatology
”
Studysummary This study found that after 15 months of treatment with ritlecitinib, patients with alopecia areata and less than 95% initial hair loss experienced significant hair regrowth, though those with more extensive hair loss showed more variable improvement.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on academic.oup.com →